Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix binding

OLFML2A ADAMTS5 CCN1 ITGB1

2.19e-0573454GO:0050840
Pubmed

Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer.

CCN1 ITGB1

4.91e-06345221618249
Pubmed

Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).

CCN1 ITGB1

4.91e-06345212826661
Pubmed

Renal macrophages monitor and remove particles from urine to prevent tubule obstruction.

ZBTB46 ITGB1

1.63e-05545238159573
Pubmed

Signal regulatory protein molecules are differentially expressed by CD8- dendritic cells.

SIRPD SIRPG

1.63e-05545216785533
Pubmed

Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo.

CCN1 ITGB1

1.63e-05545219364818
Pubmed

Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.

CCN1 ITGB1

1.63e-05545212364323
Pubmed

Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.

CCN1 ITGB1

2.45e-05645218687805
Pubmed

A nomenclature for signal regulatory protein family members.

SIRPD SIRPG

2.45e-05645216339511
Pubmed

RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1.

RANBP9 ITGB1

2.45e-05645214722085
Pubmed

The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency.

CD69 CORO1B

5.86e-05945218836449
Pubmed

Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin.

RANBP9 CMPK1

1.07e-041245215606899
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

RANBP9 CYLD MED20 RECQL GNL3L IPO9

1.75e-0464545625281560
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RANBP9 MED20 MYOF RECQL CORO1B IPO9 CCN1 ITGB1

1.77e-04124745827684187
Pubmed

Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation.

PROM1 ITGB1

1.94e-041645221067603
Pubmed

Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.

RANBP9 CYLD IPO9

1.99e-048745317148452
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

LY6G5B CYLD RECQL CLMP KBTBD4 HYDIN

2.44e-0468645629987050
Pubmed

WNT/β-catenin signaling plays a crucial role in myoblast fusion through regulation of nephrin expression during development.

MYOF ITGB1

2.47e-041845230389854
Pubmed

ILK modulates epithelial polarity and matrix formation in hair follicles.

PROM1 ITGB1

2.76e-041945224371086
Pubmed

Counteractive and cooperative actions of muscle β-catenin and CaV1.1 during early neuromuscular synapse formation.

CCN1 ITGB1

2.76e-041945235340430
Pubmed

Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins.

OCIAD1 ITGB1

3.38e-042145223284715
Pubmed

UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.

MIA3 CORO1B KBTBD4 ATP4A

3.95e-0426745433417871
Pubmed

Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.

RANBP9 IPO9 OCIAD1 ITGB1

4.18e-0427145425737280
Pubmed

Foxc2 is essential for podocyte function.

CCN1 ITGB1

4.44e-042445231062503
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

RANBP9 MYOF RECQL CORO1B GNL3L IPO9 ITGB1 ALG5

4.65e-04144045830833792
Pubmed

Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans.

RMDN3 SLC25A15

4.82e-042545219372376
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

RANBP9 ZNF462 CORO1B CCN1

4.85e-0428245423667531
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

RANBP9 CYLD RMDN3 CLMP GNL3L ZC3H3 ARRDC4

5.37e-04111645731753913
Pubmed

The basement membrane of hair follicle stem cells is a muscle cell niche.

PROM1 ITGB1

6.06e-042845221335239
Pubmed

Defining the membrane proteome of NK cells.

RECQL MIA3 GNL3L IPO9 OCIAD1 ITGB1 ALG5

7.04e-04116845719946888
Pubmed

Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.

CYLD IPO9 KBTBD4 ALG5

7.52e-0431745411042152
Pubmed

Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.

PROM1 MYOF CMPK1 CORO1B OCIAD1 ITGB1

7.99e-0485945631536960
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

RMDN3 MIA3 CORO1B OCIAD1 ITGB1

8.14e-0456845537774976
Pubmed

Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.

PROM1 ITGB1

9.48e-043545218676816
Pubmed

LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.

MYOF CORO1B IPO9 ITGB1

1.02e-0334445430333137
Pubmed

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.

CD69 SIRPG

1.06e-033745219430480
Pubmed

SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.

MED20 OLFML2A ZNF766 KBTBD4 B3GNT5 SLC25A15

1.11e-0391545632393512
Pubmed

Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.

IPO9 ITGB1 ALG5

1.18e-0316045331678930
Pubmed

Endothelial Cyp26b1 restrains murine heart valve growth during development.

ADCY4 ADAMTS5 CCN1

1.24e-0316345335364055
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

RMDN3 MIA3 GNL3L IPO9 CCN1 ALG5

1.29e-0394245631073040
Cytoband1p22.3

CLCA1 CCN1

2.14e-04224521p22.3
GeneFamilyCD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins

SIRPD SIRPG

4.28e-055382747
GeneFamilyCD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing

IL20RB IL31RA

3.51e-0342382602
GeneFamilyADAM metallopeptidase domain containing|CD molecules

CD69 PROM1 ITGB1 SIRPG

9.14e-03394384471
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF462 ZBTB46 ZNF766 ZNF846 ZNF292

1.65e-0271838528
CoexpressionBACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP

MYOF CCN1 PRSS12

1.06e-0525453M15908
CoexpressionCHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN

CYLD IL20RB CMPK1 CLMP B3GNT5 ITGB1 PRSS12

1.20e-05457457M14507
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

3.19e-06310447gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

5.41e-06336447gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlasdev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

1.07e-05373447gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlasdev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500

MYOF CLMP CLCA1 B3GNT5 CCN1

1.26e-05146445gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500

MYOF CLMP CLCA1 B3GNT5 CCN1

2.27e-05165445gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200

MYOF CLMP ADAMTS5 CLCA1

2.49e-0582444gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500

MYOF CLMP ADAMTS5 CLCA1 CCN1

3.63e-05182445gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1

4.16e-05311446gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000
CoexpressionAtlasJC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1

MYOF CLMP ADAMTS5 CCN1 ITGB1 PRSS12 BHMT2

4.33e-05464447JC_fibro_1000_K1
CoexpressionAtlasdev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1

5.49e-05327446gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500

MYOF CLMP CLCA1 B3GNT5 CCN1

6.69e-05207445gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlasdev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200

MYOF CLMP CLCA1

9.01e-0542443gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200
CoexpressionAtlasdev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500

MYOF ADAMTS5 CLCA1 SLFN13

1.51e-04130444gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlasProgenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000

MYOF ST8SIA5 CLMP IL31RA ADAMTS5 DNAH10 ITGB1 PRSS12 BHMT2

1.52e-04981449PCBC_ctl_BronchSmoothMuscl_1000
CoexpressionAtlasJC_fibro_top-relative-expression-ranked_2500_k-means-cluster#1

IL20RB CYB5D2 MYOF CCN1 ITGB1 ARRDC4 ALG5

1.58e-04571447JC_fibro_2500_K1
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500

MED20 MYOF CLMP CLCA1 B3GNT5 CCN1

2.10e-04418446gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000

MYOF CLMP CLCA1 B3GNT5 CCN1

2.13e-04265445gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200

MYOF CLMP ADAMTS5 CLCA1

2.35e-04146444gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200

MYOF CLMP ADAMTS5 CLCA1

2.41e-04147444gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlasdev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200

MYOF CLMP CLCA1 CCN1

2.81e-04153444gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlasStromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4

OLFML2A ADCY4 ADAMTS5 CLCA1 CCN1 ARRDC4

3.13e-04450446GSM777063_500
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200

CLMP CLCA1 B3GNT5 CCN1

3.41e-04161444gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200

CLMP CLCA1 CCN1

5.25e-0476443gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000

MYOF CLMP CLCA1 B3GNT5 CCN1

6.39e-04337445gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500

MYOF CLMP ADAMTS5 CLCA1 CCN1

8.18e-04356445gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlasJC_fibro_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CCN1 ITGB1 ARRDC4 PRSS12 BHMT2

8.62e-04990448JC_fibro_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500

MYOF CLMP ADAMTS5 CLCA1 CCN1

8.70e-04361445gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlasJC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#3

MIA3 IL31RA B3GNT5 ITGB1 PRSS12

8.81e-04362445JC_hmvEC_2500_K3
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500

MYOF CLMP CLCA1 B3GNT5 CCN1

9.03e-04364445gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

9.39e-04768447gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

9.76e-04773447gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000

MYOF CLMP ADAMTS5 CLCA1 B3GNT5 CCN1 SLFN13

1.01e-03777447gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-08196456d4fd5513e98eec092d51199e7f054bc15a5eaa3d
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-081964563a08209210e1a8677097a78786e00062c81b1ad2
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-08196456fddc3e89e7e6b093563655c2d02e86836cfd6da5
ToppCellCOVID-19_Convalescent-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Convalescent / Disease group, lineage and cell class

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-081964568caf4334ae692ce44e8fea5d606416afc5b72c00
ToppCellremission-CD4+_Tcm|remission / disease stage, cell group and cell class

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-08196456db7a9669ae35e2c6b465941afef9f7a6b1e7190e
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

4.48e-081964567d841113a7161b017a08602d46366ac044271b34
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

ZNF462 PROM1 ADAMTS5 CCN1 ITGB1 PRSS12

5.05e-08200456a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_Tcm|COVID-19_Convalescent / Disease, condition lineage and cell class

ZNF462 CYLD CD69 CORO1B ITGB1 SIRPG

5.05e-0820045699c5abfe96d791c60ae6021ab4201851ee4afc47
ToppCellSepsis-ICU-SEP-Lymphocyte-T/NK-CD4+_Tcm|ICU-SEP / Disease, condition lineage and cell class

CYLD CD69 CMPK1 CORO1B ITGB1 SIRPG

5.05e-08200456ed604613d547e2114f433ee49a68ca40b0ed85f7
ToppCellICU-SEP-Lymphocyte-T_NK-CD4_TCM|ICU-SEP / Disease, Lineage and Cell Type

CYLD CD69 CORO1B ITGB1 SIRPG

1.32e-061894559ed1cf4bb456780c1d1070de687bcabafd6287a3
ToppCellnormal-na-Lymphocytic_T-T4_reg-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1 SIRPG

1.36e-06190455d8c1998eb02d5105598608d4733b63978ffa3eb2
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ZNF462 CYLD CD69 CORO1B ITGB1

1.36e-061904551634a6044dce4e026a63976031a498c7460e3dce
ToppCellnormal-na-Lymphocytic_T-T4_reg|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1 SIRPG

1.36e-06190455b8897c3e0fe8bb7efaf6a3787104d454d81a4c92
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ZNF462 CYLD CD69 CORO1B ITGB1

1.36e-0619045508813c2f9321b82f0ec66854bb7a383aa1171780
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CYLD CD69 CORO1B ITGB1 SIRPG

1.43e-061924557ab626a516b07d899175ff12f1c8257688324e4b
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1 SIRPG

1.47e-061934552a06bb3d6bbe544a26dc42d94a10f60acfd3600b
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1 SIRPG

1.47e-06193455b4f8afd871fdf9418b92ff419c8ba9739b6093ca
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CYLD CD69 CORO1B ITGB1 SIRPG

1.47e-06193455194b49c152e3e3f599068ec88a7f0af6427b743a
ToppCellremission-CD4+_Tcm|World / disease stage, cell group and cell class

ZNF462 CYLD CORO1B ITGB1 SIRPG

1.54e-06195455365a06e2fb48ec5262a4e2580ba5a592e48127e0
ToppCellCOVID-19_Convalescent-CD4+_Tcm|COVID-19_Convalescent / Disease condition and Cell class

ZNF462 CYLD CD69 CORO1B ITGB1

1.58e-06196455f2a5eeb1cebde2762865ab29792370b751214c4d
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PROM1 MYOF ADAMTS5 CCN1 PRSS12

1.70e-06199455e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_Tcm|COVID-19_Mild / Disease, condition lineage and cell class

CYLD CD69 CORO1B ITGB1 SIRPG

1.75e-062004559c7e9ba7a1a6bb0e97b7b5603940da09f06a567f
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-CD4+_Tcm|Int-URO / Disease, condition lineage and cell class

CYLD CD69 CORO1B ITGB1 SIRPG

1.75e-06200455848d1f9ae79dc9d012c89fcd5cf8f2f1a7ef8e13
ToppCellsevere-CD4+_Tcm|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CYLD CD69 CORO1B ITGB1 SIRPG

1.75e-0620045546298dfa836a9f04d235939402571f7d5c10dfda
ToppCellsevere-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CYLD CD69 CORO1B ITGB1 SIRPG

1.75e-06200455e83558090a079dd9e40e0d3b5d9917fbd2695ec4
ToppCellcontrol-CD4+_Tcm|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CYLD CD69 CORO1B ITGB1 SIRPG

1.75e-062004550642d1f8f5d33fe2b2885df160be3814b3c5235f
ToppCellEndothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

OLFML2A ADCY4 ADAMTS5 BHMT2

2.54e-0516945495c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCellnormal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CMPK1 ITGB1

2.66e-0517145461318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CORO1B ITGB1 SIRPG

2.72e-051724549497948bbe53fb88c6ff6b347f743d456da587e5
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9

ST8SIA5 CLMP IL31RA B3GNT5

3.11e-05178454ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CORO1B ITGB1 SIRPG

3.11e-0517845490dedb3cef9b01907b9f8eec64218d6d2072be1f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CORO1B ITGB1 SIRPG

3.11e-05178454d6312286bf6cc5b107ccd7adb583d9667d4e1d21
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CYLD CD69 CORO1B ITGB1

3.39e-051824549ba85f621a846531a2a7861e9df695d288c9e149
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYLD CD69 CORO1B ITGB1

3.54e-05184454300edc4aa3ce55f309005c02c315fa0102ea9da7
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYLD CD69 CORO1B ITGB1

3.54e-051844548b397f9c18ed7abecdbcbd586d0ddadf07cf6e75
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

PROM1 DNAH10 SLFN13 HYDIN

3.61e-05185454f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CYLD CD69 CORO1B SIRPG

3.61e-0518545432f43ddc8a899827924834546db33928e353271b
ToppCell10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue

ZNF462 CD69 PROM1 PRSS12

3.77e-05187454f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue

ZNF462 CD69 PROM1 PRSS12

3.77e-05187454da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCellInt-URO-Lymphocyte-T_NK-CD4_TCM|Int-URO / Disease, Lineage and Cell Type

CYLD CORO1B ITGB1 SIRPG

3.77e-051874549a137961d33c6b440f1e5ef40360a365e3c03ab2
ToppCellEndothelial-B|World / lung cells shred on cell class, cell subclass, sample id

OLFML2A ADCY4 ADAMTS5 BHMT2

3.85e-051884545959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CORO1B ITGB1 SIRPG

3.85e-05188454e5c480b9a030536578f1cc91fb61738f752525b3
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CYLD CD69 CORO1B SIRPG

3.93e-051894548130102c41b2978a8b83f765ce383f836a464795
ToppCellCOVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type

PROM1 DNAH10 PRSS12 HYDIN

3.93e-0518945427329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PROM1 CLMP CCN1 ITGB1

4.01e-05190454c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc
ToppCellEpithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

PROM1 DNAH10 PRSS12 HYDIN

4.01e-05190454549d813a8f23b175875e53347928941f143e236c
ToppCellCiliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id

PROM1 DNAH10 SLFN13 HYDIN

4.01e-051904547031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCellCiliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id

PROM1 DNAH10 PRSS12 HYDIN

4.01e-05190454cd87731aaa7d252424f79cfce9f7931457f17bdf
ToppCellEpithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

PROM1 DNAH10 SLFN13 HYDIN

4.01e-05190454426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCellASK454-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

PROM1 CORO1B B3GNT5 HYDIN

4.01e-051904545cea6480f08253d7adf484e511d3fdfa96641268
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CMPK1 ITGB1

4.01e-05190454f6616b3fe7f4962249503c96c06926240066d861
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PROM1 DNAH10 PRSS12 HYDIN

4.09e-051914542a8e6d560907e71e9f6e190ca0667da804e25641
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PROM1 DNAH10 PRSS12 HYDIN

4.09e-0519145446c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCellHealthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

PROM1 DNAH10 PRSS12 HYDIN

4.09e-0519145428caedb2e448e0c7f494100d714fa7cdcf150691
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CORO1B ITGB1 SIRPG

4.09e-05191454c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCellMild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

PROM1 DNAH10 PRSS12 HYDIN

4.09e-05191454995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PROM1 DNAH10 PRSS12 HYDIN

4.09e-05191454a37f20172b85566b9039254a89680e37fd503fd5
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

PROM1 DNAH10 PRSS12 HYDIN

4.09e-051914542d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCellHealthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass

PROM1 DNAH10 PRSS12 HYDIN

4.09e-0519145415b9386b26caaa7d15f704c4a18881e1ce918a21
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PROM1 DNAH10 PRSS12 HYDIN

4.09e-05191454e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PROM1 DNAH10 PRSS12 HYDIN

4.09e-051914549d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCellHealthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass

PROM1 DNAH10 PRSS12 HYDIN

4.09e-05191454fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde
ToppCellnucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PROM1 DNAH10 PRSS12 HYDIN

4.09e-051914541c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

GNL3L IPO9 CCN1 ZNF292

4.18e-051924549cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell10x3'2.3-week_12-13-Lymphocytic_T-T_NK-CD4_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CYLD CD69 CORO1B SIRPG

4.18e-0519245428d6b159e29e6c45f3f27589bf981bab8e97068e
ToppCellHealthy-Treg|Healthy / disease group, cell group and cell class

CYLD CD69 ITGB1 SIRPG

4.18e-051924549d3795a64bf0c62f460d80730c5615869fc46933
ToppCellControl-Lymphoid_T/NK-Treg|Control / Disease group, lineage and cell class

CYLD CORO1B ITGB1 SIRPG

4.26e-05193454715f2bbee12a7952cba85d9cd8820411983ce790
ToppCellLAM-Lymphoid-T-cell|Lymphoid / Condition, Lineage and Cell class

CD69 CORO1B ITGB1 SIRPG

4.26e-051934540d9ceeb3c4d2bf5d13a29bf1b352cf2b70f3ed12
ToppCellMS-CD4|MS / Condition, Cell_class and T cell subcluster

CD69 CORO1B ITGB1 SIRPG

4.26e-05193454b579a447d5c40bde5152ed0e5d3c442c4186749f
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster

ZNF462 CLMP DNAH10 PRSS12

4.26e-051934543b927d4b8ecb21a408424ef91a23746c21741f49
ToppCellnormal-na-Lymphocytic_T-T4_em|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1

4.35e-05194454cc413fa7d24d0c821ec3a9f6a29ad50203d4fd0d
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYLD CD69 ITGB1 SIRPG

4.35e-05194454929b97eb0a4a88cd566f832d4959b8b8a34c46b4
ToppCell3'_v3-Lung-Mast|Lung / Manually curated celltypes from each tissue

ZNF462 CD69 PROM1 PRSS12

4.35e-051944545e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYLD CD69 ITGB1 SIRPG

4.35e-051944544bcbea5dc0c91c51fbb6b0f7de1e47010c62812a
ToppCellCOVID-19_Mild-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Mild / Disease group, lineage and cell class

CYLD CD69 ITGB1 SIRPG

4.35e-051944540aad8c7f356d54346af764e0cc4edce89c6daabb
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

OLFML2A MYOF RECQL ITGB1

4.35e-0519445478dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCellT/NK_cells-Regulatory_T_cell|World / Lineage and Cell class

CD69 CORO1B ITGB1 SIRPG

4.35e-051944544f55da763f63d1bf6379582e9d85796a797c5b76
ToppCellCOVID-19_Moderate-CD4+_Tcm|COVID-19_Moderate / disease group, cell group and cell class

CYLD CD69 ITGB1 SIRPG

4.35e-05194454346ab9801366501453cedd3cb7cdfb63b7e7ddf6
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CYLD CD69 ITGB1 SIRPG

4.35e-051944548c3c04770913724b4e93941b547402052ae352c2
ToppCell3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue

ZNF462 CD69 PROM1 PRSS12

4.35e-051944547b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYLD CD69 ITGB1 SIRPG

4.35e-05194454884b5c98a1fdc651d7f4a0fad2a5965859207abc
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PROM1 DNAH10 SLFN13 HYDIN

4.35e-051944544a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellnormal-na-Lymphocytic_T-T4_em-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1

4.35e-0519445429eb99bf3f9f0e2ad61747034b68e8793ad3a701
ToppCell(231)_CD4+/CD45RO+_Memory_T_cell|World / immune cells in Peripheral Blood (logTPM normalization)

CYLD CD69 CORO1B ITGB1

4.44e-05195454af9098641bce171ed3a6ac93dbafa999460bb931
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Severe / Disease group, lineage and cell class

CYLD CD69 CORO1B SIRPG

4.44e-05195454658751e384de50cdcb907d3740fb1a74004a517b
ToppCellCerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32

OLFML2A MYOF CCN1 ITGB1

4.44e-051954542192fd9b4682054776f0716933aed5a4a9412657
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYLD CD69 CORO1B SIRPG

4.44e-05195454e3e5c784e7b494434fb4f6f27e0af22b167842ef
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CYLD CD69 CORO1B SIRPG

4.44e-05195454d6b8bc4204476220a64afe17e3b6b2ed59853284
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CYLD CD69 CORO1B ITGB1

4.44e-05195454911a37684c1f93d537f51ee71cb1ccec06840315
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLMP IL31RA CCN1 ITGB1

4.44e-051954546524ee7bdc70bb5955dd6a6f134a8e6d8b5f2b39
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CD69 CORO1B ITGB1 SIRPG

4.53e-051964541f09d0a653c0ccc4d643066289f1cf1b3d6845a5
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYLD CD69 CORO1B SIRPG

4.53e-05196454459408882babf1fb56b37dc52ec119ac0b0153a7
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-CD4_TCM|Multiple_Sclerosis / Disease, Lineage and Cell Type

CYLD CORO1B ITGB1 SIRPG

4.53e-0519645430c31f3d2c1fb3667c5c7f2057eca067dcd69e4d
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD69 CORO1B ITGB1 SIRPG

4.53e-05196454ea3caea65e8ddd20a837b4322e7940328c94c15a
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster

ZNF462 CLMP DNAH10 PRSS12

4.53e-051964549401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYLD CD69 CORO1B SIRPG

4.53e-05196454a1a1e4e4404a0c590edd07dfc9e7e1b6f720fb0f
ToppCellControl-Lymphoid_T/NK-CD4+_Tcm|Control / Disease group, lineage and cell class

CD69 CORO1B ITGB1 SIRPG

4.53e-051964549a90fec4b07e07c9a3ea4d1e6c05c4b7ec699942
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD69 CORO1B ITGB1 SIRPG

4.53e-05196454f7af0af02059aefb968b72a2a27867ad8ff23614
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD69 CORO1B ITGB1 SIRPG

4.53e-05196454128bda047ffeb47fa983873737ff42603f5ffd5a
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD69 CORO1B ITGB1 SIRPG

4.53e-05196454233e77aa6302f714326ce1211f8405ebd520933c
Diseasesignal-regulatory protein beta-1 measurement

SIRPD SIRPG

8.13e-059452EFO_0802069
Diseasehydrocephalus (implicated_via_orthology)

ITGB1 HYDIN

3.83e-0419452DOID:10908 (implicated_via_orthology)
Diseasebrain aneurysm

OLFML2A PROM1 SIRPG

6.90e-04113453EFO_0003870
DiseaseNon-Small Cell Lung Carcinoma

ZNF462 CYLD ITGB1

1.75e-03156453C0007131
Diseaserheumatoid arthritis (is_marker_for)

ADAMTS5 CCN1

5.00e-0369452DOID:7148 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
KLTCRAKGTGYYVVF

ADAMTS5

666

Q9UNA0
FKYCQKYGSDKVRVI

ALG5

121

Q9Y673
VRFTYAGCLSVKKYR

CCN1

296

O00622
VVYVCGKGDSSIRYF

CORO1B

281

Q9BR76
YTCYSRGVIKVKGKG

ADCY4

1041

Q8NFM4
FTGKYGSIQYCVRAV

ARRDC4

131

Q8NCT1
ACGIYYFEVKIVSKG

RANBP9

211

Q96S59
EGVTISYKSYCKNGV

ITGB1

391

P05556
GYQRKCYFISTVKRS

CD69

91

Q07108
TYVVCRQLGFKYGKQ

PRSS12

421

P56730
KSERKGIICNYTIFY

IL31RA

446

Q8NI17
YCVKAQTFVKAIGRY

IL20RB

201

Q6UXL0
GYFAGKLSYVKTCQE

OCIAD1

86

Q9NX40
VKTISKGFFGQIYCR

B3GNT5

341

Q9BYG0
VCYDTGEKVFVSLYG

HYDIN

276

Q4G0P3
GGICQTSIYKYQKDE

BHMT2

111

Q9H2M3
YYDVKVRFIVRGCGQ

LY6G5B

61

Q8NDX9
YGQYEGKVSSVALCK

IPO9

851

Q96P70
KGTQCARIVEKYGYT

CMPK1

16

P30085
KIRSAGQKVQDCYFY

CYLD

701

Q9NQC7
FTVVKYCKGTQERGY

DNAH10

1411

Q8IVF4
TKIVEVFCGKELYGY

SLFN13

296

Q68D06
VVVTGCFGYYQEFKS

ATP4A

151

P20648
AVIRGFTYYKAGKQE

OLFML2A

286

Q68BL7
RYQYCDFLVKVGTVT

MED20

116

Q9H944
FSKAGRVYISKCYRE

RMDN3

416

Q96TC7
CRFVNFKKGDPVYVY

MIA3

61

Q5JRA6
SCNGSIYVFRDRYKK

KBTBD4

471

Q9NVX7
NKTTVYKIGDLTGYC

GNL3L

476

Q9NVN8
FEQVYSDCKKNRGTY

PROM1

556

O43490
YYRSQFKKCAVVGNG

ST8SIA5

156

O15466
SFYEKNYVCVGRVTG

CYB5D2

121

Q8WUJ1
TYYCVKFRKGSPENV

SIRPG

116

Q9P1W8
CLKTYSQVGFRGFYK

SLC25A15

51

Q9Y619
EGRYTCKVKNSGRYV

CLMP

106

Q9H6B4
YTKRCTFNKVTGLYE

CLCA1

206

A8K7I4
RYKGQSGIIYCFSQK

RECQL

311

P46063
YRCIGGVLYKVSANK

ZC3H3

601

Q8IXZ2
KECGKAFRYSTYLNV

ZNF846

481

Q147U1
TYTCKFTGCGKVYRS

ZNF292

806

O60281
DAGTYYCVKFIKGRA

SIRPD

111

Q9H106
TSRIFKQGYGAYRCK

ZNF462

1566

Q96JM2
YKCNECGKVFSRITY

ZNF766

271

Q5HY98
GSSRYFKTLYCQVQK

ZBTB46

51

Q86UZ6
SGKYCGKTQTIFLKY

MYOF

806

Q9NZM1